Bernt G. Iversen II - 20 Feb 2025 Form 4 Insider Report for Perimeter Solutions, Inc. (PRM)

Role
Director
Signature
/s/ Noriko Yokozuka, as Attorney-in-Fact
Issuer symbol
PRM
Transactions as of
20 Feb 2025
Transactions value $
$0
Form type
4
Filing time
21 Feb 2025, 16:41:35 UTC
Previous filing
29 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PRM Common Stock 127K 20 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRM Stock Option (right to buy) Award $0 +7K $0.00 7K 20 Feb 2025 Common Stock 7K $5.23 Direct F1
transaction PRM Stock Option (right to buy) Award $0 +14K $0.00 14K 20 Feb 2025 Common Stock 14K $5.50 Direct F2
transaction PRM Stock Option (right to buy) Award $0 +14K $0.00 14K 20 Feb 2025 Common Stock 14K $8.88 Direct F3
transaction PRM Stock Option (right to buy) Award $0 +17.5K $0.00 17.5K 20 Feb 2025 Common Stock 17.5K $10.13 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2024 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
F2 On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2024 were met, resulting in the cumulative vesting of the option as to 14,000 shares of common stock.
F3 On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2024 were met, resulting in the cumulative vesting of the option as to 14,000 shares of common stock.
F4 On May 3, 2022, the reporting person was granted an option to purchase 29,167 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2024 were met, resulting in the cumulative vesting of the option as to 17,500 shares of common stock.